Dry eye syndrome: Neuroptis successfully completes the pre-clinical phase for ML7
Neuroptis is looking to establish industrial and financial partnerships to commence human trials
23-Jan-2015 -
Neuroptis announced positive results from a second animal trial of its preservative-free ML7 eye drops. ML7 is intended for use in the treatment of eye surface diseases, particularly dry eye syndrome.Both animal trials demonstrated excellent local tolerance and very low systemic absorption. In ...
clinical trials
dry eye syndrome